ProShare Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $981K | Buy |
5,191
+69
| +1% | +$12.1K | ﹤0.01% | 797 |
|
|
2025
Q4 | $871K | Buy |
5,122
+382
| +8% | +$58.6K | ﹤0.01% | 868 |
|
|
2025
Q3 | $625K | Sell |
4,740
-294
| -6% | -$35.3K | ﹤0.01% | 999 |
|
|
2025
Q2 | $534K | Sell |
5,034
-281
| -5% | -$30.5K | ﹤0.01% | 1088 |
|
|
2025
Q1 | $660K | Sell |
5,315
-379
| -7% | -$49.4K | ﹤0.01% | 961 |
|
|
2024
Q4 | $701K | Sell |
5,694
-646
| -10% | -$76.1K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $706K | Sell |
6,340
-525
| -8% | -$57.5K | ﹤0.01% | 935 |
|
|
2024
Q2 | $733K | Sell |
6,865
-574
| -8% | -$63.1K | ﹤0.01% | 819 |
|
|
2024
Q1 | $896K | Buy |
7,439
+105
| +1% | +$12.9K | ﹤0.01% | 815 |
|
|
2023
Q4 | $902K | Sell |
7,334
-202
| -3% | -$25.2K | ﹤0.01% | 780 |
|
|
2023
Q3 | $975K | Sell |
7,536
-344
| -4% | -$45.8K | ﹤0.01% | 728 |
|
|
2023
Q2 | $977K | Sell |
7,880
-231
| -3% | -$31.1K | ﹤0.01% | 732 |
|
|
2023
Q1 | $1.19M | Sell |
8,111
-1,929
| -19% | -$285K | ﹤0.01% | 704 |
|
|
2022
Q4 | $1.6M | Buy |
10,040
+344
| +4% | +$50.4K | 0.01% | 657 |
|
|
2022
Q3 | $1.29M | Buy |
9,696
+396
| +4% | +$60.2K | 0.01% | 690 |
|
|
2022
Q2 | $1.45M | Sell |
9,300
-3,182
| -25% | -$490K | ﹤0.01% | 698 |
|
|
2022
Q1 | $1.94M | Sell |
12,482
-3,272
| -21% | -$475K | ﹤0.01% | 723 |
|
|
2021
Q4 | $2.01M | Sell |
15,754
-3,030
| -16% | -$398K | ﹤0.01% | 758 |
|
|
2021
Q3 | $2.45M | Buy |
18,784
+1,157
| +7% | +$175K | 0.01% | 678 |
|
|
2021
Q2 | $3.13M | Buy |
17,627
+4,437
| +34% | +$769K | 0.01% | 619 |
|
|
2021
Q1 | $2.17M | Sell |
13,190
-783
| -6% | -$129K | 0.01% | 677 |
|
|
2020
Q4 | $2.31M | Buy |
13,973
+327
| +2% | +$48.7K | 0.01% | 598 |
|
|
2020
Q3 | $1.95M | Buy |
13,646
+3,902
| +40% | +$484K | 0.01% | 577 |
|
|
2020
Q2 | $1.07M | Buy |
9,744
+908
| +10% | +$100K | 0.01% | 687 |
|
|
2020
Q1 | $881K | Sell |
8,836
-4,757
| -35% | -$615K | 0.01% | 617 |
|
|
2019
Q4 | $2.03M | Sell |
13,593
-3,073
| -18% | -$418K | 0.01% | 619 |
|
|
2019
Q3 | $2.14M | Sell |
16,666
-1,255
| -7% | -$168K | 0.01% | 572 |
|
|
2019
Q2 | $2.56M | Sell |
17,921
-4,154
| -19% | -$558K | 0.02% | 539 |
|
|
2019
Q1 | $3.16M | Sell |
22,075
-132
| -0.6% | -$17.2K | 0.02% | 504 |
|
|
2018
Q4 | $2.75M | Sell |
22,207
-4,573
| -17% | -$678K | 0.02% | 509 |
|
|
2018
Q3 | $4.5M | Buy |
26,780
+125
| +0.5% | +$21.5K | 0.03% | 445 |
|
|
2018
Q2 | $4.59M | Sell |
26,655
-2,546
| -9% | -$416K | 0.03% | 452 |
|
|
2018
Q1 | $4.41M | Sell |
29,201
-4,731
| -14% | -$694K | 0.03% | 464 |
|
|
2017
Q4 | $4.57M | Sell |
33,932
-1,353
| -4% | -$188K | 0.03% | 449 |
|
|
2017
Q3 | $5.16M | Buy |
35,285
+3,187
| +10% | +$482K | 0.05% | 369 |
|
|
2017
Q2 | $4.99M | Sell |
32,098
-1,102
| -3% | -$169K | 0.05% | 353 |
|
|
2017
Q1 | $4.82M | Sell |
33,200
-7,226
| -18% | -$941K | 0.05% | 352 |
|
|
2016
Q4 | $4.41M | Buy |
40,426
+584
| +1% | +$65K | 0.05% | 359 |
|
|
2016
Q3 | $4.84M | Sell |
39,842
-7,141
| -15% | -$963K | 0.07% | 229 |
|
|
2016
Q2 | $6.64M | Buy |
46,983
+366
| +0.8% | +$54K | 0.09% | 193 |
|
|
2016
Q1 | $6.09M | Sell |
46,617
-5,140
| -10% | -$640K | 0.08% | 210 |
|
|
2015
Q4 | $7.28M | Buy |
51,757
+2,729
| +6% | +$378K | 0.09% | 216 |
|
|
2015
Q3 | $6.51M | Sell |
49,028
-3,094
| -6% | -$533K | 0.09% | 226 |
|
|
2015
Q2 | $9.18M | Buy |
52,122
+102
| +0.2% | +$18.3K | 0.13% | 169 |
|
|
2015
Q1 | $8.99M | Buy |
52,020
+8,700
| +20% | +$1.49M | 0.11% | 205 |
|
|
2014
Q4 | $7.09M | Buy |
43,320
+10,023
| +30% | +$1.66M | 0.08% | 253 |
|
|
2014
Q3 | $5.35M | Sell |
33,297
-5,195
| -13% | -$799K | 0.07% | 273 |
|
|
2014
Q2 | $5.66M | Sell |
38,492
-8,120
| -17% | -$1.13M | 0.07% | 267 |
|
|
2014
Q1 | $6.46M | Buy |
46,612
+19,461
| +72% | +$2.93M | 0.08% | 215 |
|
|
2013
Q4 | $3.44M | Buy |
27,151
+5,169
| +24% | +$535K | 0.05% | 460 |
|
|
2013
Q3 | $2.02M | Sell |
21,982
-17,473
| -44% | -$1.41M | 0.05% | 393 |
|
|
2013
Q2 | $2.71M | Buy |
+39,455
| New | +$2.41M | 0.05% | 344 |
|
Other funds holding JAZZ
VPM
VCM
EC
ProShare Advisors's JAZZ Position: Q1 2026 in Review
ProShare Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 1.3% in Q1 2026, buying an estimated $12.1K and bringing the position to 5,191 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #797.
ProShare Advisors first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.18M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- ProShare Advisors held 5,191 shares of Jazz Pharmaceuticals worth $981K as of Q1 2026.
- ProShare Advisors bought 69 Jazz Pharmaceuticals shares in Q1 2026, an estimated $12.1K.
- Jazz Pharmaceuticals made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #797 holding.
- ProShare Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Jazz Pharmaceuticals position peaked at $9.18M in Q2 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.